Dr. Abdurrahman Yurtaslan Oncology Research and Trainee Hospital
Ankara, Yenimahalle, 06200, Turkey (Türkiye)
NCT Number: NCT04891146
The effects of different anesthesia methods on the immune system are variable. In this study, we investigated the effect of inhalation anesthesia and total intravenous anesthesia on the SII value in major abdominal cancer surgeries.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Observational
Ankara, Yenimahalle, 06200, Turkey (Türkiye)
The study was planned prospectively, observationally, on a total of 90 patients who underwent major abdominal cancer surgery. 84 patients were evaluated. The patients were seperated in two groups as inhalation anesthesia and total intravenous anesthesia (TIVA). The demographic data of the patients, type of cancer, type of surgery performed, ASA classification, preoperative chemotherapy intake, preoperative hemogram, postoperative 2nd and 24th hour hemogram, intraoperative and postoperative blood transfusion, and duration of surgery were recorded. Platelet, neutrophil, lymphocyte and SII values were saved.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Systemic Inflammatory Immune index calculated from platelet, neutrophil and lymphocyte count
Time frame: preoperative SII noted, postoperative 2.hour noted and postoperative 24.hour noted
systemic inflammatory immune index calculated by (platelet x neutrophil)/lymphocyte
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Other
The Effect of Inhalation Anesthesia and Total Intravenous Anesthesia on Systemic Inflammatory Immune Index in Major Abdominal Cancer Surgeries
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05179824
Adnexal Diseases, Bile Duct Diseases
Dallas, Texas, United States
View Trial DetailsNCT05742711
Cancer of Cervix, Cancer of Endometrium
Chennai, Tamil Nadu, India
View Trial DetailsNCT07063706
Adverse Drug Reaction (ADR), Cancer Colorectal
Rio de Janeiro, Brazil
View Trial DetailsNCT05233059
Behavior, Behavior, Health
Roanoke, Virginia, United States
View Trial Details